Tommaso Mansi

BACKGROUND: Anti-granulocyte macrophage-colony stimulating factor autoantibodies (anti-GM-CSF) have been associated with development of Crohn’s disease (CD) and complications at time of diagnosis. There are limited data on anti-GM-CSF as a prognostic biomarker in CD…

BACKGROUND. Endoscopy-based disease severity assessment in Inflammatory Bowel Disease (IBD) clinical trials is typically done using human-read scoring systems such as the Mayo Endoscopic Score (MES) or Ulcerative Colitis Endoscopic Index of Severity (UCEIS)…

BACKGROUND: Introducing Arges, an AI tool that estimates a novel continuous disease severity score in ulcerative colitis (UC) clinical trials, distinct from the traditional categorical Mayo Endoscopic subscore (MES)…